Confirmation of the safety of autologous blood donation by patients awaiting heart or lung transplantation: A controlled study using hemodynamic monitoring  by Klapper, E. et al.
CONFIRMATION OF THE 
SAFETY OF AUTOLOGOUS 
BLOOD DONATION BY 
PATIENTS AWAITING 
HEART OR LUNG 
TRANSPLANTATION 
A controlled study using 
hemodynamic monitoring 
Background: Though earlier investigations have demonstrated the efficacy 
of autologous blood transfusion in reducing allogeneic blood exposure in 
patients undergoing heart or lung transplantation, questions remain 
regarding the safety of blood donation by patients with severe heart or lung 
disease. Methods: Response to autologous blood donation by candidates for 
heart and lung transplantation a d a group of age- and gender-matched 
control subjects was studied. Heart rate, blood pressure, oxygen saturation, 
and cardiac rhythm were examined before and after phlebotomy, and 
response to orthostatic hallenge was evaluated. Patients were also ques- 
tioned regarding impressions of changes in subjective sense of well being. 
Differences between patients and control subjects were evaluated by the 
paired t test and Fisher's exact est. An alpha of 0.05 was used in all testing 
to determine statistical significance. Results: Eighteen candidates for heart 
transplantation, 16candidates for lung transplantation, and their matched 
control subjects were studied. Though patients and control subjects differed 
with respect o baseline hemodynamic measurements, significant differ- 
ences between the groups' responses to phlebotomy were not observed. 
After whole blood donation, orthostatic hallenge resulted in a mean 
change in mean arterial pressure of -2.1 mm Hg in candidates for heart 
transplantation compared with a mean of +3.6 mm Hg in their control 
subjects (p = 0.062). In candidates for lung transplantation there was a 
mean change of +2.2 mm Hg after orthostatic hallenge versus a mean 
change of +8.5 mm Hg in their control subjects (p = 0.052). Furthermore, 
no changes in cardiac rhythm or arterial oxygen saturation were detected. 
Conclusions: The hemodynamic effects of autologous blood donation in a 
group of patients with significant cardiac or pulmonary disease were not 
different from those observed in patients considered acceptable candidates 
for autologous blood collection. On the basis of these objective findings, we 
believe that patients with less severe degrees of heart or lung disease should 
not be excluded from participation i autologous blood donation programs. 
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A utologous blood predeposit and transfusion have been effectively used as alternatives to allogeneic 
blood transfusion for many years. The recent growth 
in popularity of this procedure, related directly to 
heightened awareness of the risks of allogeneic 
blood exposure, has forced the medical community 
to address issues of safety and utility of autologous 
blood collection in groups of patients commonly 
considered too ill to donate their own blood. Al- 
though some investigators have expressed concern 
about he safety of blood donation for many patients 
with underlying medical illnesses, these reservations 
have not been based on controlled studies revealing 
any demonstrable dangers for such categories of 
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patients. Furthermore, results of our studies 1 and 
those of other investigators a' 3 have suggested that 
many autologous blood programs practice overly 
restrictive policies in deciding whether to allow 
patients with significant medical abnormalities to 
donate their blood for subsequent surgical proce- 
dures. This is particularly true when patients with 
significant cardiac or pulmonary disease are consid- 
ered. 
Recently, Spiess and coworkers 4 reported the 
results of their studies of hemodynamic changes in a 
group of autologous blood donors who were consid- 
ered to be at high risk for complications from 
autologous blood donation. The majority of these 
patients had a variety of cardiovascular bnormali- 
ties. Although their studies revealed various hemo- 
dynamic alterations after blood donation, none of 
their patients demonstrated significant clinical evi- 
dence of adverse effects of the blood donation 
process. Furthermore, control patients used for this 
study consisted of healthy medical residents rather 
than age- and gender-matched subjects without 
known cardiovascular disease. 
More recently, we reported our experience in 
collecting autologous blood from patients with end- 
stage heart or lung disease awaiting organ transplan- 
tation. 5We demonstrated that such donations were 
efficacious in eliminating or reducing allogeneic 
blood exposure associated with the subsequent 
transplant operations. More important, the safety of 
autologous blood donation was suggested by a lack 
of clinically significant adverse reactions in this 
group of seriously ill patients. 
To prove the safety of autologous blood dona- 
tion for patients with extreme compromise of 
cardiac or pulmonary function, we expanded the 
scope of our studies to include more objective 
measurements of cardiac and pulmonary re- 
sponses to the blood donation process. This group 
of candidates for heart and lung transplantation 
was chosen for study to provide a model of 
patients with significant compromise of cardio- 
vascular or pulmonary function. Few blood collec- 
tion centers will routinely encounter candidates 
for heart and lung transplantation; however, the 
findings of this study can be applied to patients 
with less severe cardiopulmonary disease when 
their eligibility for autologous blood donation is 
considered. In addition, we investigated an age- 
and gender-matched control population without 
known cardiac or pulmonary disease to ascertain 
their responses to autologous blood donation. 
These latter patients were considered to be at low 
risk for phlebotomy-associated complications. For 
these studies we used a battery of noninvasive 
assessments of cardiorespiratory function before, 
during, and after phlebotomy. 
Patients and methods 
All patients accepted as heart or lung transplant 
candidates were considered potential study partici- 
pants. Eighteen candidates for heart transplantation 
and 16 candidates for lung transplantation were stud- 
ied. Patients were evaluated before each donation to 
determine eligibility. Exclusion criteria were hematocrit 
value less than 33%, systolic blood pressure less than 90 
or greater than 200 mm Hg, diastolic blood pressure 
less than 60 or greater than 100 mm Hg or heart rate 
less than 55 or more than 120 beats/mix. Patients with 
cardiac arrhythmias (other than ventricular tachycar- 
alia) or with congestive heart failure (unless they had 
acute pulmonary edema) who were free of symptoms 
were eligible for inclusion in the study. Patients who 
required oxygen at 5 L/rain or less by nasal prongs were 
also permitted to donate. The volume of blood col- 
lected ranged from 380 to 450 ml and was dependent on 
patient weight and hematocrit value. The decision to 
replace intravascular volume with saline solution or 
albumin was made jointly by a transfusion medicine 
physician and a transplant team physician. Only those 
patients highly dependent on intravascular volume for 
maintenance of adequate cardiac output received intra- 
venous fluid replacement. 
Hemodynamic assessment of the effect of blood 
donation included measurement of heart rate and blood 
pressure in the supine, sitting, and standing positions. 
Pulse oximetry measurements and a continuous electro- 
cardiogram rhythm strip were obtained uring and for a 
30-minute period after blood donation. All patients 
were observed for at least 30 minutes after phlebotomy 
before they were allowed to ambulate. A questionnaire 
was administered after the blood donation and 24 hours 
later to evaluate subjective patient response to phlebot- 
omy. The control group of age- and gender-matched 
autologous blood donors without known heart or lung 
disease was studied in the same manner. All aspects of 
this study were reviewed and approved by the Medical 
Center's institutional review board. 
Statistical methods. The paired t test was used to 
compare baseline characteristics between patients and 
control subjects. For each group, change from baseline 
was calculated for the "postdonation" period. The 
relative magnitude of these changes was compared 
between groups by the paired t test. Event rates were 
compared between groups by Fisher's exact test. An 
alpha of 0.05 was used in all testing to determine 
statistical significance and all testing was two-sided. 
Results 
Although patients and control subjects might 
have donated more than 1 unit of blood in prepa- 
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Table I. Age, gender, hematocrit value, and volume replacement 
Age (yr) 
Mean Range Gender 
Hematocrit 
Mean ++_ SD Range 
No. of patients 
receiving volume 
replacement 
Candidates for heart transplantation 55 36-68 M, 18 
(n = 18) 
Control subjects (n = 18) 55 36-68 Matched 
Candidates for lung transplantation 47.4 27-65 M, 7; F, 9 
(n = 16) 
Control subjects (n = 16) 47.6 29-63 Matched 
41.4% ± 3.2% 36%748% 6 
41.6% + 3.2% 37%-50% 0 
46.0% -+ 7.1% 37%-65% 3 
40.1% + 3.7% 35%-47% 0 
M, Male; F, female; SD, standard eviation. 
Table II. Heart rate measured in supine position 
Heart rate (beats~rain) 
Predonation 
(mean +- SE) 
Postdonation Mean change 
(mean +_ SE) (range) p Value 
Candidates for heart transplantation 
Control subjects 
Candidates for lung transplantation 
Control subjects 
85.5 -+ 2.95 
65.1 +- 3.17 
94.9 -+ 4.27 
71.9 -+ 2.11 
82.8 -+ 3.33 -2.7 (+8 to -16) 0.2 
64.0 + 3.35 -1.1 (+9 to -10) 
89.9 -+ 3.69 -5.0 (+5 to -18) 0.3 
71.3 -+ 2.23 -0.6 (+6 to -6)  
SE, Standard error. 
ration for the operation, for purposes of statistical 
analysis only the first donation was used for calcu- 
lation of the groups' mean responses to phlebotomy. 
Age, gender, and predonation hematocrit values for 
patients and control subjects are shown in Table I. 
Candidates for lung transplantation had diagnoses 
of primary pulmonary hypertension, pulmonary fi- 
brosis, or emphysema nd candidates for heart 
transplantation had diagnoses of ischemic cardio- 
myopathy or idiopathic dilated cardiomyopathy. 
Volume replacement was provided to the three 
patients with primary pulmonary hypertension and 
to six candidates for heart transplantation with right 
ventricular disease. These patients had severe right- 
sided heart failure and were thought o be highly 
dependent on intravascular volume to maintain car- 
diac output (Table I). 
Mean baseline heart rate was higher in the can- 
didates for cardiac transplantation than in the con- 
trol subjects. Mean heart rate in the supine position 
was 85.5 beats/rain in the patient group versus 65.1 
beats/min in the control group (/2 < 0.01). After 
donation there was little change in mean heart rate 
measured in the supine position with no significant 
difference between patients and control subjects in 
their response to phlebotomy (Table II). 
Before phlebotomy, mean heart rate was higher in 
the group of candidates for lung transplantation 
when compared with that of their control subjects. 
In the supine position, the baseline mean heart rate 
of candidates for transplantation was 94.9 beats/min 
whereas that of the control subjects was 71.9 beats/ 
min (p < 0.01). After blood donation, the mean 
heart rate of candidates for transplantation de- 
creased to 89.9 beats'rain whereas that of control 
subjects remained essentially unchanged (p -- 0.3) 
(Table II). 
Baseline mean arterial pressures in candidates for 
heart transplantation a d control subjects were not 
significantly different and in response to phlebotomy 
demonstrated little change (Table III). In candi- 
dates for lung transplantation, mean arterial pres- 
sure before and after phlebotomy was significantly 
greater than that in their control subjects (p < 0.05), 
but there was no significant difference in their 
responses to blood donation (Table III). 
Responses of heart rate and mean arterial pres- 
sure to an orthostatic hallenge before and after 
phlebotomy are shown for patients and control 
subjects in Tables IV and V. Before blood donation 
the mean heart rate of candidates for heart trans- 
plantation increased 1.4 beats/min, whereas that of 
control subjects increased 8 beats/min when they 
were raised from a supine to a standing position 
(p = 0.138) (Table IV). After blood donation, mean 
heart rate in candidates for heart transplantation 
and their control subjects increased, with that in 
control subjects increasing more than that in pa- 
tients (15.2 versus 3.5 beats/rain, p = 3.0006) (Table 
IV). 
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Table III. Mean arterial pressure measured in supine position 
Mean arterial pressum (ram Hg) 
Predonation 
(mean + SE) 
Postdonation 
(mean +_ SE) 
Mean change 
O'ange) p Value 
Candidates for heart transplantation 
Control subjects 
Candidates for lung transplantation 
Control subjects 
84.4 ± 2.8 
92.5 _+ 3.17 
97.5 ± 2.47 
87.4 + 3.91 
83.5 _+ 2.25 
91.9 ± 3.03 
94.4 ± 3.15 
83.9 _+ 3.11 
-0.9 (+13 to -10) 
-0.6 (+12 to -12) 
-3.1 (+I8 to -20) 
-3.5 (+12 to -21) 
0.9 
0.9 
SE, Standard error. 
Table IV. Heart rate response to orthostatic hallenge 
Heart rate (beats~±in) 
Supine (mean ++_ SE) Standing (mean ± SE) Change p Value 
Predonation 
Candidates for heart transplantation 85.5 _+ 2.85 86,9 _+ 3.42 
Control subjects 65.1 _+ 3.17 73,1 ± 3.15 
Candidates for lung transplantation 94.9 ± 4.27 101.7 _+ 5.69 
Control subjects 71.9 ± 2.11 78.0 ± 2.86 
Postdonation 
Candidates for heart transplantation 82.8 _+ 3.33 86.3 _+ 4.14 
Control subjects 64.9 ± 3.35 80.1 ± 3.75 
Candidates for lung transplantation 89.9 _+ 3.69 102.0 _+ 5.66 













SE, Standard error. 
Table V. Mean arterial pressure response to orthostatic hallenge 
Mean arterial pressure (ram Hg) 
Supine (mean ± SE) Standing (mean ± SE) Change p Value 
Predonation 
Candidates for heart transplantation 
Control subjects 
Candidates for lung transplantation 
Control subjects 
Postdonation 
Candidates for heart transplantation 
Control subjects 
Candidates for lung transplantation 
Control subjects 
84.3 + 2.80 82.2 -+ .75 -2.1 0.011 
92.5 ± 3.17 95.8 -+ 3.28 +3.3 
97.5 ± 2.47 96.3 -+ 2.91 -1.2 0.016 
87.4 -+ 3.91 93.2 ± 3.90 +5.8 
83.5 ± 3.33 81.2 -+ 3.18 -2.3 0.062 
91.9 ± 3.03 95.5 -+ 3.35 +3.6 
94.4 ± 3.15 96.6 ± 2.23 +2.2 0.052 
83.9 ± 3.11 92.4 ± 4.55 +8.5 
SE, Standarderror. 
Before donation, mean arterial pressure exhibited 
small changes in candidates for heart transplanta- 
tion and control subjects when donors were sub- 
jected to an orthostatic challenge. After donation, 
similar changes were observed (Table V). 
Candidates for lung transplantation and control 
subjects had similar increases in heart rate when 
they were raised from a supine to standing position 
before phlebotomy. After blood donation, the mean 
heart rate of patients and control subjects increased 
similarly (Table IV). 
Before donation, candidates for lung transplanta- 
tion and control subjects differed in mean arterial 
pressure response to an orthostatic hallenge. Mean 
arterial pressure in patients remained essentially 
unchanged, whereas mean arterial pressure in the 
control group increased slightly (p = 0.016) (Table 
V). Postdonation mean arterial pressure increased 
in both candidates for lung transplantation and 
control subjects, but more so in the control group 
(p = 0.052) (Table V). 
Oxygen saturation values for candidates for trans - 
plant and control subjects are shown in Table VI. 
Values in candidates for lung transplantation dif- 
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Table VI. Arterial oxygen saturation 
Arterial oxygenation saturation (%) 
Predonation Postdonation Change 
(mean +_ SE) (mean +_ SE) (mean +_ SE) p Value 
Candidates for heart transplantation 
Control subjects 
Candidates for lung transplantation 
Control subjects 
96.8 _+ 0.4 97.2 _+ 0.4 +0.4 _+ 0.4 0.6 
96.9 _+ 0.5 97.6 +_ 0.3 +0.7 _+ 0.3 
95.3 + 0.9 95.9 _+ 0.8 +0.6 + 0.5 0.3 
98.6 _+ 0.4 98.6 + 0.3 0 _+ 0.2 
SE, Standard error. 
Table VII. Number of untoward responses elicited by postphlebotomy questionnaire 
Immediately During 24 hr 
postdonation p Va lue  postdonation p Value 
Candidates for heart transplantation 5* (28%) 0.045 i t  (5%) 1.00 
Control subjects 0 (0%) 0 (0%) 
Candidates for lung transplantation 1:) (6%) 1.00 2§ (13%) 1.00 
Control subjects 2§ (13%) 3§ (18%) 
*Transient lightheadedness in four patients; mild transient diaphoresis in one patient. 
tTransient lightheadedness. 
SMild fatigue. 
§Mild fatigue or transient lightheadedness. 
fered from those in control subjects both before and 
after phlebotomy (p < 0.05) and no change in 
oxygen saturation was observed after the blood 
donation. No differences in oxygen saturation were 
observed between candidates for heart transplanta- 
tion and control subjects before or after phlebot- 
omy. No new cardiac arrhythmias were noted on 
electrocardiogram in any patients or control subjects 
in either of the two study groups. 
Donor responses to a series of questions were 
actively solicited immediately after and 24 hours 
after phlebotomy (Table VII). The intent was to 
elicit any subtle subjective change in well-being that 
was not observed. With the exception of one candi- 
date for heart transplantation who had mild dia- 
phoresis after donation, no donor had a donor 
reaction characterized by increased vagal tone. A 
mild, transient sensation of lightheadedness was the 
most common response, and no patient required 
treatment for any adverse vent after donation. 
Discussion 
The data collected in this study provide important 
new information regarding the hemodynamic re- 
sponse to blood donation by patients with severe 
cardiac or pulmonary disease. Because control sub- 
jects were matched for age and gender, it was 
possible to compare accurately the study groups' 
responses to phlebotomy with those of patients 
currently thought o be medically eligible for autol- 
ogous blood donation. Although the two popula- 
tions of patients differed significantly in baseline 
hemodynamic haracteristics, their responses to 
phlebotomy were essentially similar. Although some 
differences in measured parameters between pa- 
tients and control subjects reached statistical signif- 
icance, in all instances the magnitude of difference 
was clinically insignificant. Neither group demon- 
strated significant hemodynamic compromise as a 
result of blood donation. 
Interestingly, control patients in our study had a 
significantly different increase in heart rate when 
they were raised to the standing position after 
phlebotomy compared with that in patients with 
cardiopulmonary disease. This may have been re- 
lated to the study patients' underlying cardiovascu- 
lar abnormalities and to the effects of drug therapy 
they were receiving, which may have prevented 
increases in heart rate in response to orthostatic 
challenge. However, neither group encountered sig- 
nificant reduction in blood pressure from orthostatic 
challenge after blood donation. Most important, no 
donor had significant clinical consequences of phle- 
botomy. 
When questioned, candidates for heart transplan- 
tation reported a negative subjective impression 
after phlebotomy more frequently than did their 
control subjects (p = 0.045). However, these symp- 
toms of lightheadedness or diaphoresis were mild 
and transient. No patient was deferred from further 
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participation in the autologous blood predeposit 
study as the result of a poor response to prior blood 
donation. Twenty-four hours after donation, no 
difference in adverse response rate could be de- 
tected. For the group of candidates for lung trans- 
plantation and their control subjects, subjective re- 
sponse to blood donation was similar. 
The report of Spiess and coworkers 4 has raised 
concern that patients with cardiovascular disease 
might be at increased risk for hemodynamic com- 
promise after autologous blood donation. Our stud- 
ies indicate that such patients' responses do not 
significantly differ from those of patients considered 
to be acceptable autologous blood donors as ascer- 
tained by hemodynamic measurements b fore and 
after the blood donation process. The fact that our 
patients had less severe alteration i  blood pressure 
after blood onation than those in the report by 
Spiess and co-workers 4 may relate to the fact that 
none of our patients was allowed to ambulate for at 
least 30 minutes after the blood donation process. It 
is reasonable that patients with a history of cardio- 
pulmonary disease might require an increased re- 
covery period after the blood donation process 
before being allowed to ambulate. Most important, 
we believe that our data and those presented by 
Spiess and coworkers 4 demonstrate that patients 
with severe cardiopulmonary d sfunction do not 
have significant clinical complications after the 
blood donation process. 
Though we encountered no dangerous reactions, 
patients awaiting organ transplantation are best 
cared for in a hospital blood donor facility, where 
full medical support is available. For this study, we 
chose patients with the most extreme degree of 
heart or lung disease to serve as a model for 
autologous donation that may reasonably be applied 
to the much larger population of patients with less 
severe disease who may go to a blood center for 
collection of autologous blood. Certainly the fact 
that our patients with the most severe degrees of 
cardiopulmonary compromise were found to partic- 
ipate in autologous blood donation without signifi- 
cant clinical response indicates that those patients 
with less severe degrees of cardiopulmonary disease 
can easily tolerate the stress of autologous blood 
donation without significant concern. 
Although some of our patients were given volume 
replacement with saline solution or albumin after 
blood donation, no attempt was made to study the 
need for volume replacement or the lack thereof. 
Only those patients with severe right-sided heart 
failure were preselected to receive volume replace- 
ment. Evaluation of the necessity or possible benefit 
of this procedure was beyond the scope of this study. 
However, it should be noted that patients with 
extremely severe cardiac compromise (without 
right-sided failure) tolerated blood donation with- 
out adverse ffects in the absence of volume replace- 
ment. Therefore we believe that volume replace- 
ment is probably unnecessary for the vast majority 
of patients with cardiac disease who might be con- 
sidered for autologous blood donation. 
The size of our study population poses the poten- 
tial that a relatively small risk from blood donation 
might not have been detected for patients with severe 
cardiopulmonary compromise. However, the known 
risks of allogeneic blood transfusions are real and 
suggest that a small risk that might accompany autol- 
ogous blood donation might be tolerable in an effort o 
spare patients the complications of allogeneic blood 
transfusions. Though advancements in donor screen- 
ing and laboratory testing of donated blood have 
increased the safety of transfusion therapy, we must 
heed the lessons learned during the past 15 years. 
No one could have anticipated the spread of human 
immunodeficiency virus by blood transfusion. 
Therefore we believe that these findings provide 
strong reasons to allow patients with known cardio- 
vascular or pulmonary disease to participate in autol- 
ogous blood donation programs o as to minimize 
their exposure to allogeneic transfusion and the poten- 
tial complications associated with such therapy. 
REFERENCES 
1. Mann M, Sacks HJ, Ooldfinger D. Safety of autologous 
blood donation prior to elective surgery for a variety of 
potentially "high-risk" patients. Transfusion 1983;23: 
229-32. 
2. AuBuchon JP, Popovsky MA. The safety of preopera- 
tive autologous blood donation in the non-hospital 
setting. Transfusion 1991;31:513-7. 
3. Owings DV, Kruskall MS, Thurer RL, Donovan LM. 
Autologous blood donations prior to elective cardiac 
surgery: safety and effect on subsequent blood use. 
JAMA 1989;262:1963-8. 
4. Spiess BD, Sassetti R, McCarthy RJ, Narbone RF, 
Tuman K J, Ivankovich AD. Autologous blood dona- 
tion: hemodynamics in a high-risk patient population. 
Transfusion 1992;32:17-22. 
5. Goldfinger D, Capon S, Czer L, et al. Safety and 
efficacy of preoperative donation of blood for autolo- 
gous use by patients with end-stage heart or lung 
disease who are awaiting organ transplantation. Trans- 
fusion 1993;33:336-40. 
